HIV-2 Continues to Decrease, Whereas HIV-1 is Stabilizing in Guinea-Bissau
Overview
Authors
Affiliations
Objective: Although Guinea-Bissau has the world's highest prevalence of HIV-2, it has been decreasing since 1987. Meanwhile, the prevalence of HIV-1 has been increasing. We describe both the prevalence and changes in incidence of HIV-2 and HIV-1 during the last 30 years of observation in the capital Bissau in Guinea-Bissau.
Methods: A total of 3125 adults living in 412 houses in Bissau were eligible for inclusion in the present cross-sectional survey conducted from November 2014 to February 2016. All participants had a questionnaire filled out and a blood sample taken. Results were compared with previous surveys.
Results: Of the 3125 eligible adults, 2601 (83.2%) individuals participated. The overall prevalence of HIV decreased from 8.6% (218/2548) in 2006 to 6.7% (173/2601) in 2016 with an age-adjusted and sex-adjusted prevalence ratio (aPR) of 0.71 [95% confidence interval (CI) = 0.59-0.85]. Including HIV-1/2 dual infections, a decrease in the overall prevalence of HIV-2 from 4.4% (112/2548) to 2.8% (72/2601) was observed with an aPR of 0.55 (95% CI = 0.41-0.73). The overall prevalence of HIV-1 decreased from 4.6% (118/2548) to 4% (104/2601) with an aPR of 0.81 (95% CI = 0.63-1.05). Incidence rates for HIV-2 and HIV-1, estimated for 815 individuals, decreased from 0.24 to 0.09 and from 0.50 to 0.40 per 100 person-years of observation, respectively, in the periods between 1996-2006 and 2006-2016.
Conclusion: The prevalence of HIV-2 continues to decrease, whereas the prevalence of HIV-1 showed sign of stabilization. The results observed may be explained by a lower pathogenicity of HIV-2 and changes in risk behavior.
Are Confirmatory Assays Reliable for HIV-1/HIV-2 Infection Differentiation? A Multicenter Study.
Guiraud V, Bocobza J, Desmonet M, Damond F, Plantier J, Moreau G J Clin Microbiol. 2023; 61(8):e0061923.
PMID: 37458587 PMC: 10446874. DOI: 10.1128/jcm.00619-23.
Diallo I, Ouedraogo S, Sawadogo A, Ouedraogo G, Diendere E, Zoungrana J J Int Assoc Provid AIDS Care. 2022; 21:23259582221143675.
PMID: 36474417 PMC: 9732798. DOI: 10.1177/23259582221143675.
Bohlbro A, Mendes A, Sifna A, Gomes V, Rudolf F, Wejse C Infection. 2022; 51(4):955-966.
PMID: 36417172 DOI: 10.1007/s15010-022-01958-w.
SARS-CoV-2 seroprevalence among people living with HIV in Guinea-Bissau.
Dutschke A, Wejse C, Nanque J, Medina C, Honge B, Jespersen S Public Health. 2022; 209:36-38.
PMID: 35785597 PMC: 9157020. DOI: 10.1016/j.puhe.2022.05.017.
Nielsen S, Fisker A, da Silva I, Byberg S, Biering-Sorensen S, Bale C EClinicalMedicine. 2022; 49:101467.
PMID: 35747181 PMC: 9156892. DOI: 10.1016/j.eclinm.2022.101467.